Shares of Envision Healthcare Co. (NYSE:EVHC) have been assigned an average recommendation of “Hold” from the nineteen analysts that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, eight have given a hold rating and nine have given a buy rating to the company. The average 1 year price target among brokers that have covered the stock in the last year is $39.82.
Several equities research analysts have recently commented on EVHC shares. Cantor Fitzgerald lowered shares of Envision Healthcare from an “overweight” rating to a “neutral” rating and set a $30.00 price target for the company. in a report on Wednesday, November 1st. Jefferies Group set a $71.00 price target on shares of Envision Healthcare and gave the company a “buy” rating in a report on Wednesday, November 1st. KeyCorp set a $67.00 price target on shares of Envision Healthcare and gave the company a “buy” rating in a report on Wednesday, November 1st. Mizuho set a $57.00 price target on shares of Envision Healthcare and gave the company a “hold” rating in a report on Tuesday, October 31st. Finally, Bank of America lowered shares of Envision Healthcare from a “buy” rating to a “neutral” rating and set a $32.00 price target for the company. in a report on Thursday, November 2nd.
Envision Healthcare (NYSE EVHC) traded down $0.37 during trading hours on Tuesday, hitting $37.70. 2,290,000 shares of the stock traded hands, compared to its average volume of 2,350,000. Envision Healthcare has a twelve month low of $23.77 and a twelve month high of $73.00. The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.00 and a current ratio of 3.01. The company has a market cap of $4,560.00, a price-to-earnings ratio of -25.30, a P/E/G ratio of 0.97 and a beta of 0.57.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. PNC Financial Services Group Inc. raised its stake in shares of Envision Healthcare by 1.5% during the 2nd quarter. PNC Financial Services Group Inc. now owns 4,848 shares of the company’s stock worth $304,000 after acquiring an additional 70 shares in the last quarter. Palisade Capital Management LLC NJ bought a new position in shares of Envision Healthcare during the 3rd quarter worth approximately $229,000. HighTower Advisors LLC raised its stake in shares of Envision Healthcare by 30.7% during the 2nd quarter. HighTower Advisors LLC now owns 5,936 shares of the company’s stock worth $371,000 after acquiring an additional 1,395 shares in the last quarter. CIBC World Markets Inc. bought a new position in shares of Envision Healthcare during the 4th quarter worth approximately $208,000. Finally, OLD Mutual Customised Solutions Proprietary Ltd. raised its stake in shares of Envision Healthcare by 88.2% during the 4th quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 6,401 shares of the company’s stock worth $221,000 after acquiring an additional 3,000 shares in the last quarter.
ILLEGAL ACTIVITY NOTICE: “Brokerages Set Envision Healthcare Co. (EVHC) Price Target at $39.82” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/02/18/brokerages-set-envision-healthcare-co-evhc-price-target-at-39-82.html.
About Envision Healthcare
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.